Tandem Study: Type 2 Diabetes Patients Benefit from AID
September 16, 2025
This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS)
This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS)
Medtronic plc, a leading company in healthcare technology, has received two major approvals from the FDA that expand the features of its MiniMed 780G insulin